THERACEA PHARMA

theracea-pharma-logo

TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders. TheraCea Pharma, a University of Arizona spin-off based in Tucson, developed and licensed radiochemistry technology that allows for high-efficiency and rapid fluorine-18 radiolabeling of biomolecules for clinical and research applications.

#SimilarOrganizations #People #Financial #Website #More

THERACEA PHARMA

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2019-01-01

Address:
Paradise Valley, Arizona, United States

Country:
United States

Website Url:
http://www.theracea.com

Total Employee:
1+

Status:
Active

Total Funding:
256 K USD


Similar Organizations

not_available_image

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.

Current Employees Featured

not_available_image

Justin Jeffery
Justin Jeffery Co-Founder & CBO @ TheraCea Pharma
Co-Founder & CBO
2019-10-01

iman-daryaei_image

Iman Daryaei
Iman Daryaei Co-Founder & CEO @ TheraCea Pharma
Co-Founder & CEO
2019-10-01

Founder


iman-daryaei_image

Iman Daryaei

not_available_image

Justin Jeffery

Investors List

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - TheraCea Pharma

Official Site Inspections

http://www.theracea.com

  • Host name: 198.49.23.145
  • IP address: 198.49.23.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "TheraCea Pharma" on Search Engine

TheraCea Pharma - Crunchbase Company Profile & Funding

Company Type For Profit. TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders. TheraCea Pharma, a โ€ฆSee details»

TheraCea Pharma Company Profile 2024: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for TheraCea Pharma. Use the PitchBook Platform to explore the full profile.See details»

TheraCea Pharma | LinkedIn

TheraCea Pharma is a radiopharmaceutical company that develops PET imaging agents using a proprietary chemical process that allows efficient "shake and bake" 18F-labeling โ€ฆSee details»

Pipeline โ€” TheraCea

Product Pipeline. TheraCea is independently and collaboratively developing products with our radiolabeling centered on 18F because of its clinical, logistical, economic, and โ€ฆSee details»

Innovative Biotech Startup, TheraCea Pharma, Wins a Year in โ€ฆ

Nov 12, 2020 TheraCea Pharma is an R&D stage Arizona-based biotechnology company that develops diagnostic positron emission tomography (PET) imaging agents for the โ€ฆSee details»

TheraCea Pharma - Funding, Financials, Valuation & Investors

TheraCea Pharma has raised a total of. $256K. in funding over 1 round. This was a Grant round raised on Aug 15, 2021. TheraCea Pharma is funded by National Science โ€ฆSee details»

TheraCea Pharma LC | VentureRadar

TheraCea Pharma LC | VentureRadar. Location: USA. Founded in 2019. Private Company. Develops innovative diagnostic agents for cancer detection, focusing on breast cancer โ€ฆSee details»

Innovative Startup Focused on Developing Clinical Diagnostic โ€ฆ

Feb 29, 2024 TheraCea is unleashing the power of precision medicine by developing clinical diagnostic tools for faster and more accurate detection of cancer and โ€ฆSee details»

Tech Talk: Personalized cancer vaccines, virtual STEM, and โ€ฆ

Nov 25, 2020 Biotechnology company TheraCea Pharma is the winner of the University of Arizonaโ€™s Center for Innovation Sponsored Launch Fueled by the Bioindustry โ€ฆSee details»

UA opens new biotech-focused business incubator in Oro Valley

May 19, 2021 TheraCea is led by co-founder and CEO Iman Daryaei, who got his doctorate in biological chemistry from the UA in 2016; co-founder and chief business โ€ฆSee details»

Innovative Biotech Startup, TheraCea Pharma ... - University of โ€ฆ

TheraCea Pharma is a R&D stage Arizona-based biotechnology company that develops diagnostic positron emission tomography (PET) imaging agents for the detection of โ€ฆSee details»

Technology โ€” TheraCea

TheraCea creates radiotracer and detection technology for the development of and application in cancer and neurological therapies. The Science. The core of our โ€ฆSee details»

TheraCea Pharma - Contacts, Employees, Board Members

TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders.See details»

Startups Prove Ecosystem Power at IdeaFunding 2021

Apr 26, 2021 TheraCea Pharma. Yet another UArizona startup, TheraCea, received the $1,000 Peopleโ€™s Choice award. The company is working to bring to market a new โ€ฆSee details»

TheraCea Pharma - Overview, News & Similar companies

Is TheraCea Pharma a public company? See more information about TheraCea Pharma. View TheraCea Pharma (www.theracea.com) location in Arizona, United States , โ€ฆSee details»

Grant - TheraCea Pharma - 2021-08-15 - Crunchbase

Aug 15, 2021 Organization Name. TheraCea Pharma. Announced Date Aug 15, 2021. Funding Type Grant. Money Raised. $256K. Lead Investors. National Science โ€ฆSee details»

Maker of ALS drug pulls Relyvrio off the market, keeping a ... - NPR

17 hours ago The unusual decision brought praise from both patients and critics of the pharmaceutical industry. "I think Amylyx did right," says Brooke Eby, a Maryland โ€ฆSee details»

Services โ€” TheraCea

Services. Experience seamless support during your preclinical studies with TheraCea. TheraCea can assist with custom synthesis of biologicals, radiolabeling, as well as โ€ฆSee details»

TheraCea Pharma - Crunchbase

TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders. Search Crunchbase. Start Free Trial . Chrome โ€ฆSee details»

WHO prequalifies new dengue vaccine | Reuters

16 hours ago Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon Purchase Licensing Rights. May 15 โ€ฆSee details»